Unbalanced Vitreous Levels of Osteoprotegerin, RANKL, RANK, and TRAIL in Proliferative Diabetic Retinopathy

Overview

Journal Ocul Immunol Inflamm

Publisher Informa Healthcare

Specialty Ophthalmology

Date 2017 Sep 16

PMID 28914577

Citations 6

Authors

Ahmed M Abu El-Asrar

Ajmal Ahmad

Kaiser Alam

Emilie Bittoun

Mohammad Mairaj Siddiquei

Ghulam Mohammad

Ahmed Mousa

Gert De Hertogh

Ghislain Opdenakker

Affiliations

Soon will be listed here.

Abstract

Purpose: We investigated the expression of the proinflammatory and proangiogenic factor osteoprotegerin (OPG) and its ligands, receptor activator of nuclear factor-κB ligand (RANKL), tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), and the receptor RANK in proliferative diabetic retinopathy (PDR).

Materials And Methods: Vitreous samples from PDR and nondiabetic control patients and epiretinal membranes from PDR patients were studied by enzyme-linked immunosorbent assay, immunohistochemistry, and Western blot analysis.

Results: Vascular endothelial growth factor, OPG, and soluble RANK levels in vitreous samples from PDR patients were significantly higher than that in nondiabetic controls. Soluble TRAIL levels were significantly lower in PDR patients than that in nondiabetic control, whereas soluble RANKL levels did not differ significantly. RANKL, RANK, and TRAIL were expressed in vascular endothelial cells, myofibroblasts, and CD45-expressing leukocytes in PDR epiretinal membranes.

Conclusions: Dysregulated expression of OPG/RANKL/RANK pathway and TRAIL might be related to inflammation and angiogenesis in PDR.

Citing Articles

MiR-217 regulates autophagy through OPG/RANKL/RANK in giant cell tumors.

Meng C, Jiang B, Liu W, Wang L, Zhao Z, Bai R J Orthop Surg Res. 2023; 18(1):346.

PMID: 37165403 PMC: 10170763. DOI: 10.1186/s13018-023-03826-1.

Palmitic Acid Induced a Long-Lasting Lipotoxic Insult in Human Retinal Pigment Epithelial Cells, which Is Partially Counteracted by TRAIL.

Sergi D, Zauli E, Casciano F, Secchiero P, Zauli G, Fields M Antioxidants (Basel). 2022; 11(12).

PMID: 36552548 PMC: 9774631. DOI: 10.3390/antiox11122340.

Familial Paget's disease of bone with ocular manifestations and a novel TNFRSF11A duplication variant (72dup27).

Saito-Hakoda A, Kikuchi A, Takahashi T, Yokoyama Y, Himori N, Adachi M J Bone Miner Metab. 2022; 41(2):193-202.

PMID: 36520195 DOI: 10.1007/s00774-022-01392-w.

Changes in aqueous and vitreous inflammatory cytokine levels in proliferative diabetic retinopathy: a systematic review and meta-analysis.

Mason R, Minaker S, Lahaie Luna G, Bapat P, Farahvash A, Garg A Eye (Lond). 2022; .

PMID: 35672457 DOI: 10.1038/s41433-022-02127-x.

Repositioning the Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) on the TRAIL to the Development of Diabetes Mellitus: An Update of Experimental and Clinical Evidence.

Koliaki C, Katsilambros N Int J Mol Sci. 2022; 23(6).

PMID: 35328646 PMC: 8949963. DOI: 10.3390/ijms23063225.